GlassScriptPhysician profile
Christina E Barett
NPI 1336685387
$971.60
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $342 · 2022: $529 · 2023: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $100.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $198.21 | 2021-2023 | |
| Scynexis, INC. | $115.30 | 2021-2022 | |
| Organon LLC | $104.68 | 2021-2023 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $103.17 | 2021-2023 | |
| Evofem Biosciences, INC. | $69.84 | 2021-2022 | |
| Therapeuticsmd, INC. | $66.23 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $64.97 | 2021-2022 | |
| Exeltis, USA INC. | $62.68 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $57.14 | 2022-2023 | |
| Agile Therapeutics, INC. | $53.96 | 2021 | |
| Merck Sharp & Dohme LLC | $25.08 | 2021 | |
| Heron Therapeutics, INC. | $23.07 | 2022 | |
| Shield Therapeutics INC | $13.67 | 2023 | Accrufer |
| Aspira Women'S Health INC | $13.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Barett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.